Scholarlink

<p>Human papillomavirus (HPV) types 16 and 18 are major causes of cervical cancer, with their E6 oncogenes serving as key biomarkers for early diagnosis. Traditional molecular detection methods, such as PCR, are commonly used but still have limitations, including false positives and complex procedures. To address these challenges, we developed an amplification-free sandwich direct&#xa0;enzyme-linked immunoassay (sELISA). This assay combined the S9.6 antibody’s specificity for DNA-RNA hybrids with streptavidin-polymeric horseradish peroxidase (SA-polyHRP) for signal enhancement. The SA-polyHRP direct sELISA achieved a detection limit of 1.03&#xa0;pM (0.012&#xa0;pg/µL), demonstrating 59.6-fold higher sensitivity than the indirect sELISA using SA-coated plates with HRP-labeled secondary antibody (monomeric HRP) for tracer. The integral evaluation of immunoassays containing specificity, affinity, and robustness was accomplished by assessing selectivity for nucleic acid structure, length, GC content variations, and subtypes, respectively. Additionally, the assay was successfully applied to artificial plasma samples, showing acceptable recovery rates (76–108%) at various dilutions and further validating its potential for clinical diagnostics. Overall, this assay using the SA-polyHRP-based direct sELISA provided a rapid, highly specific, and sensitive diagnostic tool for the detection of HPV-related cancers, which will offer significant improvements in diagnostic accuracy, screening, and monitoring.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

An immunoassay based on polyHRP signal amplification for HPV16/18 E6 RNA detection with anti-DNA-RNA hybrid antibody

  • 期刊论文

  • 发表日期：

    2025年6月18日

查看全文
  • Mingxia Lin,
  • Yikui Zou,
  • Lian Yu,
  • Huanxin Xiao,
  • Weiguang Chen,
  • Qianchen Xuan,
  • Xiping Cui,
  • Suqing Zhao

摘要

Human papillomavirus (HPV) types 16 and 18 are major causes of cervical cancer, with their E6 oncogenes serving as key biomarkers for early diagnosis. Traditional molecular detection methods, such as PCR, are commonly used but still have limitations, including false positives and complex procedures. To address these challenges, we developed an amplification-free sandwich direct enzyme-linked immunoassay (sELISA). This assay combined the S9.6 antibody’s specificity for DNA-RNA hybrids with streptavidin-polymeric horseradish peroxidase (SA-polyHRP) for signal enhancement. The SA-polyHRP direct sELISA achieved a detection limit of 1.03 pM (0.012 pg/µL), demonstrating 59.6-fold higher sensitivity than the indirect sELISA using SA-coated plates with HRP-labeled secondary antibody (monomeric HRP) for tracer. The integral evaluation of immunoassays containing specificity, affinity, and robustness was accomplished by assessing selectivity for nucleic acid structure, length, GC content variations, and subtypes, respectively. Additionally, the assay was successfully applied to artificial plasma samples, showing acceptable recovery rates (76–108%) at various dilutions and further validating its potential for clinical diagnostics. Overall, this assay using the SA-polyHRP-based direct sELISA provided a rapid, highly specific, and sensitive diagnostic tool for the detection of HPV-related cancers, which will offer significant improvements in diagnostic accuracy, screening, and monitoring.

Graphical abstract